(Q22248031)

PubMed

8 February 2023

J. C. S. Breitner

series ordinal

2

author given names

J C S

author last names

Breitner

1 reference

PubMed

8 February 2023

P. P. Zandi

series ordinal

3

author given names

P P

author last names

Zandi

1 reference

PubMed

International Review of Psychiatry

8 February 2023

language of work or name

English

0 references

publication date

January 2007

0 references

published in

0 references

volume

19

0 references

issue

6

0 references

page(s)

693-706

0 references

cites work

Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

20 April 2017

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

20 April 2017

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

20 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Randomized pilot study of nimesulide treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Resveratrol--a boon for treating Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

High-dose estradiol improves cognition for women with AD: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effects of cognitive training interventions with older adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Use of ramipril in preventing stroke: double blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Analysis of plasma tocopherols alpha, gamma, and 5-nitro-gamma in rats with inflammation by HPLC coulometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Fitness effects on the cognitive function of older adults: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Exercise: a behavioral intervention to enhance brain health and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

An active and socially integrated lifestyle in late life might protect against dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Ginkgo biloba: A Cognitive Enhancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Association between nutritional status and cognitive functioning in a healthy elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Alzheimer Disease in the US Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Epidemiology of dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Diet and the risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Ginkgo biloba for cerebral insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Hyperinsulinemia and risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Double placebo design in a prevention trial for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Total serum homocysteine in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Free testosterone and risk for Alzheimer disease in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Curry consumption and cognitive function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Cohort study of vitamin C intake and cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Mediterranean diet and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The relation between antioxidants and memory performance in the old and very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Obesity, abdominal obesity and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Statin Use and the Risk of Incident Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Relation of plasma lipids to Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Links between the pathology of Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Mediterranean diet and risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Alzheimer disease: mechanistic understanding predicts novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Update on hypertension and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Statin therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Cognitive reserve and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

NSAIDs for the Chemoprevention of Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Prevention of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Association of metabolic syndrome with Alzheimer disease: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Immunology and immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Long-term effects of cognitive training on everyday functional outcomes in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

Effects of Estrogen Plus Progestin on Risk of Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Behavior-based interventions to enhance cognitive functioning and independence in older adults

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Risk of mortality with vitamin E supplements: the Cache County study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Folates and prevention of disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

An editorial update: Annus horribilis for vitamin E

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

10.1080/09540260701797944

Identifiers

DOI

0 references